Alfante, Baby Boy .
HRN: 24-80-85 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/23/2024
AMPICILLIN 1GM (VIAL)
04/23/2024
04/29/2024
IV
150mg
Q12
MSAF
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes